Close Menu
MarketForces AfricaMarketForces Africa
    What's Hot

    NGX Group Acquires 10% Stake in Nairobi Securities Exchange

    November 16, 2026

    South African Rand Slips to R16.67 Amid Broad US Dollar Rally

    November 16, 2026

    Wall Street, European Stocks Mixed as Nvidia CEO Exit Alters Sentiment

    November 16, 2026
    Facebook X (Twitter) Instagram
    Trending
    • NGX Group Acquires 10% Stake in Nairobi Securities Exchange
    • South African Rand Slips to R16.67 Amid Broad US Dollar Rally
    • Wall Street, European Stocks Mixed as Nvidia CEO Exit Alters Sentiment
    • Seplat Energy Target Price Hikes to N17,588 at CardinalStone
    • Oando Soars Amidst Plan to Cure Negative Equity, Pay Dividend
    • S&P Casts Doubt on Nigeria’s 2029 Investment Grade Ambition – CSL
    • Money Market Rates Shift as Banking Liquidity Surplus Drops
    • XRP Rebounds as Dip Buyers Accumulate after Price Hits Multi-Year Low
    • Home
    • About Us
    Facebook X (Twitter) Instagram LinkedIn WhatsApp TikTok Telegram
    MarketForces AfricaMarketForces Africa
    Subscribe
    Monday, November 16
    • Home
    • News
    • Analysis
    • Economy
    • Mobile Banking
    • Entrepreneurship
    MarketForces AfricaMarketForces Africa
    MarketForces Africa » MarketForces News » World Health Organisation Clears BioNTech’s COVID-19 Vaccine for Emergency Use

    World Health Organisation Clears BioNTech’s COVID-19 Vaccine for Emergency Use

    Marketforces AfricaBy Marketforces AfricaJanuary 1, 2021Updated:February 11, 2026 News No Comments2 Mins Read
    World Health Organisation Clears BioNTech’s COVID-19 Vaccine for Emergency Use
    Share
    Facebook Twitter LinkedIn Pinterest Email Tumblr Reddit Telegram WhatsApp Copy Link

    World Health Organisation Clears BioNTech’s COVID-19 Vaccine for Emergency Use

    The World Health Organisation, WHO, has cleared BioNtech COVID-19 vaccine for emergency use, the authority has revealed amidst rising infections rate.

    To speed up access to COVID-19 vaccinations in the developing world, on the eve of the New Year, the UN health agency approved Pfizer and BioNTech’s vaccine for emergency use.

    Regulatory experts convened by WHO from around the world and UN agency’s own teams reviewed the data on the Pfizer/BioNTech vaccine and found on Thursday that it met WHO’s must-have criteria for safety and efficacy – with its benefits offsetting any potential risks.

    “This is a very positive step towards ensuring global access to COVID-19 vaccines,” said Dr. Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products.

    “But I want to emphasise the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere.”

    A UN statement said the move opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.

    Read Also: AfDB approves $27.33m for AU’s COVID-19 response initiative

    It also enables UNICEF and the Pan-American Health Organization (PAHO) to procure the vaccine for distribution to countries in need.

    The statement said at the same time, WHO is encouraging more developers to come forward for review and assessment to satisfy the critical supply for all countries globally to stem the pandemic.

    “WHO and our partners are working night and day to evaluate other vaccines that have reached safety and efficacy standards,” said Dr. Simão.

    The statement said drawing from WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) population prioritization  recommendations for COVID-19 vaccines, which were issued in September, the group will convene on 5 January to formulate vaccine specific policies and recommendations.

    Meanwhile, WHO is working with regional partners to advise national health authorities about the two-dose shot and its anticipated benefits.

    WHO, with the GAVI Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), are spearheading a global effort called COVAX to secure the equitable distribution of vaccines to all countries and not just to wealthy nations.

    World Health Organisation Clears BioNTech’s COVID-19 Vaccine for Emergency Use

    Pfizer
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Marketforces Africa
    • Website
    • Facebook
    • X (Twitter)
    • Instagram
    • LinkedIn

    MarketForces Africa, a Financial News Media Platform for Strategic Opinions about Economic Policies, Strategy & Corporate Analysis from today's Leading Professionals, Equity Analysts, Research Experts, Industrialists and, Entrepreneurs on the Risk and Opportunities Surrounding Industry Shaping Businesses and Ideas.

    Keep Reading

    NGX Group Acquires 10% Stake in Nairobi Securities Exchange

    South African Rand Slips to R16.67 Amid Broad US Dollar Rally

    Wall Street, European Stocks Mixed as Nvidia CEO Exit Alters Sentiment

    Seplat Energy Target Price Hikes to N17,588 at CardinalStone

    Oando Soars Amidst Plan to Cure Negative Equity, Pay Dividend

    S&P Casts Doubt on Nigeria’s 2029 Investment Grade Ambition – CSL

    Add A Comment

    Comments are closed.

    Editors Picks

    NGX Group Acquires 10% Stake in Nairobi Securities Exchange

    November 16, 2026

    South African Rand Slips to R16.67 Amid Broad US Dollar Rally

    November 16, 2026

    Wall Street, European Stocks Mixed as Nvidia CEO Exit Alters Sentiment

    November 16, 2026

    Seplat Energy Target Price Hikes to N17,588 at CardinalStone

    November 16, 2026

    Oando Soars Amidst Plan to Cure Negative Equity, Pay Dividend

    November 16, 2026
    Latest Posts

    NGX Group Acquires 10% Stake in Nairobi Securities Exchange

    November 16, 2026

    South African Rand Slips to R16.67 Amid Broad US Dollar Rally

    November 16, 2026

    Wall Street, European Stocks Mixed as Nvidia CEO Exit Alters Sentiment

    November 16, 2026

    Seplat Energy Target Price Hikes to N17,588 at CardinalStone

    November 16, 2026

    Oando Soars Amidst Plan to Cure Negative Equity, Pay Dividend

    November 16, 2026

    Subscribe to News

    Get latest news from MarketForces Africa...

    Advertisement
    Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

    News

    • World
    • Politics
    • Economy
    • Business
    • Opinions
    • Fintech
    • Science & Technology

    Company

    • About us
    • Advertising
    • Classified Ads
    • Contact Info
    • Editorial Policy

    Services

    • Subscriptions
    • Research
    • Due Diligence
    • Newsletters
    • Sponsored News
    • Work With Us

    Subscribe to Updates

    Subscribe to updates from MarketForces Africa, an independent financial news service provider.

    © 2026 MarketForces Africa. All rights reserved.
    • Privacy Policy
    • Terms
    • Accessibility

    Type above and press Enter to search. Press Esc to cancel.